Thyrocare Technologies (NSE:THYROCARE) Days Sales Outstanding : 25.72 (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Thyrocare Technologies Days Sales Outstanding?

Thyrocare Technologies's average Accounts Receivable for the three months ended in Mar. 2024 was ₹435 Mil. Thyrocare Technologies's Revenue for the three months ended in Mar. 2024 was ₹1,543 Mil. Hence, Thyrocare Technologies's Days Sales Outstanding for the three months ended in Mar. 2024 was 25.72.

The historical rank and industry rank for Thyrocare Technologies's Days Sales Outstanding or its related term are showing as below:

NSE:THYROCARE' s Days Sales Outstanding Range Over the Past 10 Years
Min: 1.35 Med: 10.97 Max: 61.79
Current: 39.14

During the past 10 years, Thyrocare Technologies's highest Days Sales Outstanding was 61.79. The lowest was 1.35. And the median was 10.97.

NSE:THYROCARE's Days Sales Outstanding is ranked better than
84.55% of 220 companies
in the Medical Diagnostics & Research industry
Industry Median: 69.44 vs NSE:THYROCARE: 39.14

Thyrocare Technologies's Days Sales Outstanding declined from Mar. 2023 (58.51) to Mar. 2024 (25.72).

Thyrocare Technologies Days Sales Outstanding Historical Data

The historical data trend for Thyrocare Technologies's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thyrocare Technologies Days Sales Outstanding Chart

Thyrocare Technologies Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Days Sales Outstanding

Get a 7-Day Free Trial

11.96

22.50

42.73

61.79

41.04

Thyrocare Technologies Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															58.51	57.58	34.13	37.49	25.72

Competitive Comparison of Thyrocare Technologies's Days Sales Outstanding

For the Diagnostics & Research subindustry, Thyrocare Technologies's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Thyrocare Technologies's Days Sales Outstanding Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Thyrocare Technologies's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Thyrocare Technologies's Days Sales Outstanding falls into.

Thyrocare Technologies Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Thyrocare Technologies's Days Sales Outstanding for the fiscal year that ended in Mar. 2024 is calculated as

	Days Sales Outstanding (A: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (851.2	+	434.7)	/	2 )	/	5718.8	*	365
=	642.95					/	5718.8	*	365
=	41.04

Thyrocare Technologies's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (0	+	434.7)	/	1 )	/	1542.5	*	365 / 4
=	434.7					/	1542.5	*	365 / 4
=	25.72

Thyrocare Technologies (NSE:THYROCARE) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Thyrocare Technologies Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Thyrocare Technologies's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Thyrocare Technologies (NSE:THYROCARE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Thyrocare Technologies Ltd (NSE:THYROCARE) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

539871:India

Address

D-37/1, TTC Industrial Area, MIDC, Turbhe, Opposite Sandoz, Navi Mumbai, MH, IND, 400703

Website

https://www.thyrocare.com

Thyrocare Technologies Ltd is a diagnostics & research company. The company has three business segments: Diagnostic Testing Services, Imaging Services, and Other. The Diagnostic Testing Services segment provides a medical diagnostic investigation into thyroid disorders, metabolism disorders, diabetes, anemia, infertility, auto-immunity, and other infectious diseases. The company primarily earns majority of its revenue from Diagnostic Testing Services segment. The Imaging Services segment operates a network of imaging centers focused on early and effective cancer monitoring. The Other business segment provides miscellaneous services. The company earns the vast majority of its revenue in India.

Thyrocare Technologies (NSE:THYROCARE) Headlines

No Headlines